Item |
Interventional treatment group |
Chinese herb group |
Sex |
|
|
Male |
56 |
60 |
Female |
9 |
7 |
Age (years) |
|
|
Median |
51 |
51 |
Range |
25-75 |
16-83 |
Serum hepatitis B surface antigen |
|
|
Positive |
58 |
59 |
Negative |
7 |
8 |
Serum AFP (ng/mL) |
|
|
<20 |
18 |
15 |
21-400 |
6 |
6 |
≥400 |
41 |
46 |
Child-Pugh Classification |
|
|
A |
51 |
43 |
B |
14 |
24 |
Portal vein thrombosis |
|
|
Positive |
45 |
44 |
Negative |
20 |
23 |
ECOG performance status |
|
|
1 |
40 |
29 |
2 |
22 |
31 |
3 |
3 |
7 |
Tumor burden (tumor/non-tumor) |
|
|
≥50% |
41 |
36 |
<50% |
24 |
21 |
The number of tumor |
|
|
1 |
37 |
30 |
≥2 |
28 |
37 |
Abdominal lymph node metastasis |
|
|
Positive |
27 |
29 |
Negative |
38 |
38 |
Distant metastasis |
|
|
Positive |
18 |
26 |
Negative |
37 |
41 |
AFP, alpha-fetoprotein; ECOG, the Eastern Cooperative Oncology Group |